Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has removed a detailed citation of a clinical trial related to Cabozantinib and Sunitinib, which may affect the availability of important information regarding treatment options for metastatic renal cell carcinoma.
    Difference
    0.4%
    Check dated 2025-05-07T01:28:08.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-30T00:20:10.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a clinical trial for cabozantinib in non-small cell lung cancer, while adding a new version revision and a brief mention of the CRETA trial.
    Difference
    24%
    Check dated 2025-04-22T18:13:28.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-08T09:33:42.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T07:34:19.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T09:57:35.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.